| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.50B | 11.84B | 11.48B | 12.54B | 11.85B | 8.95B |
| Gross Profit | 6.00B | 5.50B | 5.11B | 5.51B | 5.30B | 3.69B |
| EBITDA | 6.31B | 7.63B | 12.54B | 6.20B | 7.47B | 6.56B |
| Net Income | 7.11B | 7.98B | 6.42B | 8.01B | 8.37B | 5.20B |
Balance Sheet | ||||||
| Total Assets | 176.72B | 169.47B | 172.31B | 172.16B | 178.69B | 170.06B |
| Cash, Cash Equivalents and Short-Term Investments | 12.24B | 14.18B | 15.67B | 9.63B | 9.98B | 11.29B |
| Total Debt | 33.74B | 34.55B | 37.49B | 35.48B | 37.71B | 40.15B |
| Total Liabilities | 50.72B | 48.04B | 51.47B | 55.83B | 60.13B | 62.67B |
| Stockholders Equity | 109.17B | 105.35B | 103.68B | 96.97B | 98.26B | 87.89B |
Cash Flow | ||||||
| Free Cash Flow | 6.32B | 7.35B | 4.67B | 5.94B | 5.74B | 2.50B |
| Operating Cash Flow | 7.25B | 8.55B | 5.98B | 7.46B | 7.57B | 4.29B |
| Investing Cash Flow | -1.01B | 345.00M | 2.57B | -3.82B | -4.08B | -6.16B |
| Financing Cash Flow | -4.63B | -9.64B | -7.11B | -4.90B | -6.13B | 4.38B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | HK$62.17B | 4.19 | 6.71% | 5.72% | 9.00% | -4.33% | |
74 Outperform | HK$20.55B | 8.82 | 5.04% | 4.97% | 7.26% | 6.73% | |
67 Neutral | HK$4.12B | 6.18 | 4.48% | 6.69% | -0.49% | -8.15% | |
67 Neutral | HK$61.07B | 7.92 | 11.78% | 5.34% | 3.68% | 7.86% | |
65 Neutral | HK$38.40B | 651.97 | 3.74% | 3.23% | -0.18% | 24.50% | |
64 Neutral | HK$21.76B | 8.50 | 8.16% | 3.47% | 3.31% | 2.16% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |